Could a common drug prevent brain damage after a stroke?
NCT ID NCT07249853
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether the drug cilostazol can prevent delayed brain injury in people who have had a bleeding stroke from a burst aneurysm. About 316 adults will receive either cilostazol or a placebo for 14 days. The goal is to see if the drug reduces the risk of delayed brain damage and improves long-term recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cilostazol
- What this could lead to
- If it works, this could provide a new way to prevent delayed brain damage after a bleeding stroke, improving recovery.
- What could go wrong
- This is a phase 3 trial, but results are not yet available. The drug may not reduce complications or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood pressure cuff shield the brain after a severe stroke?
- Can a gentle ear zap calm the Brain's overactive 'Fight or Flight' response?
- Spinal zap may stop deadly brain artery spasms after aneurysm
- Brain pressure sensor may guide better recovery after aneurysm rupture
- Brain bleed breakthrough? new drug could stop fluid buildup without surgery
- Nerve block may boost brain recovery after hemorrhagic stroke